TRX2 has been tested by Oxford Biolabs in a clinical study. In the study, 59 male and female volunteers showing signs of alopecia completed 18 months of therapy, receiving either TRX2 or a placebo.
The results of the study showed that 26 (out of a total 29) participants who had taken TRX2 recorded and increase of at least 10% in the number of hair strands in the evaluation area and/or a 10% increase in hair weight.
In January 2014 the UK Advertising Standards Authority upheld a complaint against TRX2 and Oxford Biolabs, citing that advertisements that the company had run for TRX2 were misleading and in breach of EU advertising codes. The company agreed and changed their advertising in line with the code of conduct.
- Tyler, Richard (9 January 2011). "Thomas Whitfield's German roots help hair loss product launch". The Daily Telegraph. Retrieved 23 July 2012.
- Tyler, Richard (16 January 2009). "Thomas Whitfield: The Oxford student who plans to make baldness a thing of the past". The Daily Telegraph. Retrieved 23 July 2012.
- Edwards, Jim (12 January 2011). "Pharma's 4 Best Shots at a Cure for Baldness" (Web). CBSNews.com. CBS News. Retrieved 1 August 2012.
it's actually just another dietary supplement and as such doesn't need to be approved by the FDA.
- "Oxford BioLabs". Oxford BioLabs. Retrieved 1 December 2017.
- "Carnipure" (Web). Lonza. Retrieved October 22, 2012.
- "Minoxidil Alternatives" (Web). MPB Research. Retrieved 1 August 2012.
- "TRX2® HAIR SUPPLEMENT CLINICAL STUDY" (Web). Oxford BioLabs. Retrieved 1 December 2017.
- "ASA Adjudication on Oxford Biolabs Ltd" (Web). Advertising Standards Authority. Retrieved 1 December 2017.
- TRX2, Product Website